Table 2.
The demographic data and urinary suPAR levels of patients and controls
| Primary FSGS | Minimal change disease | Membranous nephropathy | Secondary FSGS | Normal control | |
|---|---|---|---|---|---|
| Number of subjects |
62 |
13 |
22 |
13 |
26 |
| Age (median, range) |
28, 13 to 84 |
46, 18 to 71 |
50, 40 to 78 |
40, 15 to 46 |
27, 22 to 47 |
| Gender (male/female) |
42/20 |
6/7 |
15/7 |
4/9 |
10/16 |
| Urinary suPAR/urine creatinine (pg/μmol) (median, IQR) | 500.56, 262.78 to 1,059.44 | 307.86, 216.54 to 480.18 | 250.23, 170.37 to 357.59 | 220.45, 149.38 to 335.54 | 183.59, 103.92 to 228.78 |
FSGS, focal segmental glomerulosclerosis; IQR, inter-quartile range; suPAR, soluble urokinase receptor.